Trial
NCT01163838
Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia
Phase IWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
Pfizer
Collaborators
—
Condition
Hypercholesterolemia
Intervention
Placebo
Why stopped
Study was redesigned based on FDA feedback.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-23